Ligand id: 9729

Name: olamkicept

Compound class Peptide or derivative
International Nonproprietary Names
INN number INN
10311 olamkicept
FE 999301 | FE-301 | FE-999301 | TJ301
Olamkicept is a recombinant protein that fuses the extracellular domain of the signal transducing subunit of the IL-6 receptor, IL-6Rβ (glycoprotein 130, gp130), to a human IgG Fc fragment [3]. The full construct is a dimer of covalently linked identical peptide chains. Mechanistically olamkicept acts as an inhibitor of the IL-6 signalling pathway. Olamkicept inhibits trans signalling by the soluble IL-6 receptor (sIL-6R) [1], a mechanism that is involved in human inflammatory and autoimmune diseases [2]. It is hypothesised to be clinically effective in reducing disease signs and symptoms whilst not being detrimental to the role of IL-6 in the acute immune response to infection.
Database Links
Specialist databases
IMGT/mAb-DB 730
Other databases
GtoPdb PubChem SID 354702205
Search PubMed clinical trials olamkicept
Search PubMed titles olamkicept
Search PubMed titles/abstracts olamkicept